Low molecular weight heparin for outpatient treatment of venous thromboembolism. safe, effective, and cost reducing?
Koopman
Maria M W
MM
Bossuyt
Patrick M M
PM
D000553:Ambulatory Care / Q000191:economics; D003362:Cost-Benefit Analysis / Q000191:economics; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000191:economics / Q000628:therapy; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000191:economics / Q000628:therapy*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight